A very positive result; let’s hope that this drug can at minimum provide the patients and thier families with a way to stabilise the disease a5 minimum. Really hope the6 allow compassionate use for those that wish to accept the risk of using an early stage drug that has not. completed phase 2b and phase 3 testing.
- Forums
- ASX - By Stock
- PER
- Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations
Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-5
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.003(3.57%) |
Mkt cap ! $73.02M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.1¢ | $17.84K | 219.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 141084 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 59816 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 141084 | 0.081 |
5 | 18604 | 0.080 |
2 | 121300 | 0.077 |
1 | 130000 | 0.076 |
4 | 223335 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.083 | 59816 | 1 |
0.084 | 129242 | 3 |
0.085 | 4326 | 1 |
0.086 | 55000 | 1 |
0.087 | 125000 | 1 |
Last trade - 13.13pm 26/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |